Cargando…
Is the ‘blue’ colour convention for inhaled reliever medications important? A UK-based survey of healthcare professionals and patients with airways disease
In many countries, short-acting β(2)-agonist inhalers have traditionally been coloured blue. This inhaled therapy has also conventionally been known as a ‘reliever’ by patients and healthcare professionals (HCPs), in comparison with ‘preventer’ medications (inhaled steroids). With the rapidly changi...
Autores principales: | Fletcher, Monica, Scullion, Jane, White, John, Thompson, Bronwen, Capstick, Toby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093406/ https://www.ncbi.nlm.nih.gov/pubmed/27808097 http://dx.doi.org/10.1038/npjpcrm.2016.81 |
Ejemplares similares
-
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry
por: Capstick, Toby G D, et al.
Publicado: (2021) -
Inhalation Therapy of Calcitonin Relieves Osteoarthritis of the Knee
por: Armagan, Onur, et al.
Publicado: (2012) -
Determinants of Colour Constancy and the Blue Bias
por: Weiss, David, et al.
Publicado: (2017) -
When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals
por: Gaduzo, S, et al.
Publicado: (2019) -
Aphonia of Twenty Months Standing, Relieved by Iodine Inhalation
por: Stevens, Edward B.
Publicado: (1853)